Morten Hasselstrøm Jensen

Morten Hasselstrøm Jensen is a Professor at Aalborg University Hospital's Department of Health Science and Technology, affiliated with the Faculty of Medicine. He holds additional roles as Data Lead Project Director at Novo Nordisk A/S and previously served as Senior Researcher at Steno Diabetes Center North Denmark. His research focuses on diabetes management, telemedicine, and glycemic control, particularly in insulin-treated populations. He leads projects like ADAPT-T2D (cloud-based personalized diabetes treatment) and Sten-O Starter (clinical effects of diabetes management tools).

• Education: Formal academic qualifications not explicitly listed in the provided text.

Jensen's research interests include optimizing insulin therapy, predicting hypoglycemia, and leveraging machine learning for clinical decision support. His work emphasizes translating data into actionable insights for diabetes care, such as continuous glucose monitoring (CGM) analysis and telemonitoring systems. Key contributions include studies on cardiovascular risks in diabetes patients and adherence to insulin regimens.

His articles explore topics like CGM data analysis, glycemic variability, and AI-driven treatment titration. Projects highlight interdisciplinary collaboration across clinical, engineering, and computational domains.

• Grants & Awards: No specific awards mentioned, but his projects (e.g., ADAPT-T2D) are funded through institutional and industry partnerships.
• Advising: Supervised 8 PhD students (names not listed).

Jensen collaborates with Steno Diabetes Center and Novo Nordisk, contributing to clinical trials and digital health solutions aimed at improving diabetes outcomes through technology integration.